Showing results (1201-1210 of 1,380) with videos related to
Sort By:
Pageof 138
JAMA Oncology|July 17, 2015
Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group StudySmita Bhatia, Wendy Landier, Lindsey Hageman, et al.Heredity|May 4, 2018
Incorporating non-equilibrium dynamics into demographic history inferences of a migratory marine speciesE L Carroll, R Alderman, J L Bannister, et al.Blood|July 1, 2015
Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232Michael J Borowitz, Brent L Wood, Meenakshi Devidas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology groupSmita Bhatia, Wendy Landier, Muyun Shangguan, et al.Pediatric Blood & Cancer|March 11, 2015
Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434Stuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, et al.Leukemia|November 2, 2021
Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232Michael J Burke, Meenakshi Devidas, Zhiguo Chen, et al.JACC. Advances|September 17, 2025
Prognostic Value of Exercise Stress Echocardiography for Patients With Breast Cancer Treated With Chest RadiotherapyRafael E Toro Manotas, Mariana Garcia Arango, Renzo J Mogollon, et al.Blood|September 28, 2006
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)Kirk R Schultz, D Jeanette Pullen, Harland N Sather, et al.Leukemia|February 24, 2021
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631Patrick A Brown, John A Kairalla, Joanne M Hilden, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2017
Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1Wendy Landier, Lindsey Hageman, Yanjun Chen, et al.Pageof 138